Home 5 Articles 5 Exact Sciences Ends Cologuard Co-promotion Partnership with Pfizer

Exact Sciences Ends Cologuard Co-promotion Partnership with Pfizer

by | Jan 5, 2022

One of the most dynamic and significant marketing arrangements in the genetic cancer lab testing market over the last few years is coming to an end. On Nov. 30, Exact Sciences told investors it is ending its collaboration with Pfizer to co-promote the firm’s flagship Cologuard colorectal cancer screening test. Not only will Pfizer stop […]

This content is exclusive to Lab Industry Report subscribers

Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.